Matthew Young
Scientist and coauthor on psychedelic and MDMA/psilocybin research publications
Papers
7 publications
Trials
0 clinical trials
Key Impact
He appears on multiple influential papers linking MDMA to fear extinction and psilocybin to treatment-resistant depression, including clinical and translational studies in psychedelic psychiatry.
Background & Research
Matthew B. Young is a researcher whose published work spans preclinical MDMA studies and clinical psilocybin research. His papers include seminal translational work on fear extinction and later studies on psilocybin outcomes in treatment-resistant depression, suggesting a role bridging basic neuroscience and psychiatric therapeutics.
Collaboration Network
17 collaborators· click a node to visit their profile
Full network →